- Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines
Hitoshi Masuo et al, 2023, Cancer Science CrossRef - n‐6 and n‐3 Fatty acids and their metabolites augment inhibitory action of doxorubicin on the proliferation of human neuroblastoma (IMR‐32) cells by enhancing lipid peroxidation and suppressing Ras, Myc, and Fos
Anasuya Devi Hari et al, 2018, BioFactors CrossRef - A novel cross-communication of HIF-1α and HIF-2α with Wnt signaling in TNBC and influence of hypoxic microenvironment in the formation of an organ-on-chip model of breast cancer
Manosi Banerjee et al, 2023, Medical Oncology CrossRef - Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
Weixiao An et al, 2019, Frontiers in Pharmacology CrossRef - Study on the effects of the different polar group of EPA-enriched phospholipids on the proliferation and apoptosis in 95D cells
Yao Guo et al, 2021, Marine Life Science & Technology CrossRef - Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review
Muhammad Asif Ali et al, 2024, Food Science & Nutrition CrossRef - Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells
QIU-XIANG WU et al, 2016, Oncology Reports CrossRef - HINT2 triggers mitochondrial Ca2+ influx by regulating the mitochondrial Ca2+ uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer
Linghui Chen et al, 2017, Cancer Letters CrossRef - Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
Xi Liu et al, 2021, Genes & Diseases CrossRef - Structural modification of oridonin via DAST induced rearrangement
Dong-Dong Luo et al, 2018, RSC Advances CrossRef - C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3/9 via the CD64/AKT/mTOR pathway
Xiaodong Yan et al, 2021, Human Cell CrossRef - In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS-Mediated Signalling Pathways
Wei Wu et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef - Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
Xiang Li et al, 2021, Frontiers in Pharmacology CrossRef - Recent advances in oridonin derivatives with anticancer activity
Pedro J. M. Sobral et al, 2023, Frontiers in Chemistry CrossRef - Oridonin enhances the anticancer activity of NVP-BEZ235 against neuroblastoma cells in vitro and in vivo through autophagy
Li-Di Zhang et al, 2016, International Journal of Oncology CrossRef - Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
Sajad Fakhri et al, 2022, Frontiers in Oncology CrossRef - The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Yibo Fu et al, 2021, Cells CrossRef - Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation
Mingxing Zheng et al, 2017, Molecular Medicine Reports CrossRef - Advances in the treatment of pancreatic cancer with traditional Chinese medicine
Yanhua Zhang et al, 2023, Frontiers in Pharmacology CrossRef - Research Progress and Future Development Potential of Oridonin in Pharmacological Activities
Jinhuan Jiang et al, 2023, Current Molecular Pharmacology CrossRef